Olszewska Wieslawa, Helson Rebecca, Openshaw Peter J M
Department of Respiratory Medicine, Wright Fleming Institute for Infection and Immunity, National Heart and Lung Division, Faculty of Medicine, Imperial College, St. Mary's Campus, Paddington, London W2 1PG, UK.
Expert Opin Investig Drugs. 2004 Jun;13(6):681-9. doi: 10.1517/13543784.13.6.681.
Acute respiratory virus infections cause the majority of lower respiratory tract illnesses and hospitalisations of infants and the elderly. The emergence of new respiratory viruses and a high probability that influenza will cause further pandemics highlights the necessity for developing better preventative strategies. Although there is a clear and pressing need for vaccines to prevent respiratory syncytial virus, rhinoviruses, coronaviruses, parainfluenza and human metapneumovirus, progress has been extremely slow. This review presents the current status of vaccine development for respiratory viral diseases and outlines novel approaches for the future.
急性呼吸道病毒感染是导致婴儿和老年人下呼吸道疾病及住院的主要原因。新的呼吸道病毒的出现以及流感极有可能引发更多大流行,凸显了制定更好预防策略的必要性。尽管迫切需要疫苗来预防呼吸道合胞病毒、鼻病毒、冠状病毒、副流感病毒和人偏肺病毒,但进展极其缓慢。本综述介绍了呼吸道病毒性疾病疫苗研发的现状,并概述了未来的新方法。